Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03466658 · ClinicalTrials.gov registry record · NA

Preoperative Jumpstart for Decolonization of P. Acnes

A NA study, sponsored by Milton S. Hershey Medical Center.

Terminated
Registry status
NA
Development phase
17
Enrollment target

NCT03466658: Clinical Trial NA study, sponsored by Milton S. Hershey Medical Center.

NCT03466658 is a NA study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03466658, a NA study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.

TERMINATED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

The objective of the study is to evaluate the efficacy of preoperative treatment with a novel, wireless, low-level microcurrent-generating antimicrobial device (brand name: JumpStart) in preventing the spread of Propionibacterium acnes in patients receiving open or arthroscopic shoulder surgery.

Primary Outcome

The primary outcome measures the intraoperative culture results (e.g. positive vs negative, days to positive conversion) for P. acnes by evaluating bacterial cultures from punch skin biopsies at the time of the surgery.

Interventions

  • DEVICE JumpStart Antimicrobial Wound Dressing

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2018-11-01
Est. Completion 2019-08-01
Phase NA
Milton S. Hershey Medical Center

396 total trials

Why NCT03466658 stopped before completion

NCT03466658 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which JumpStart Antimicrobial Wound Dressing is the first listed.

NCT03466658 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03466658 about?

NCT03466658 is a clinical study titled "Preoperative Jumpstart for Decolonization of P. Acnes". The objective of the study is to evaluate the efficacy of preoperative treatment with a novel, wireless, low-level microcurrent-generating antimicrobial device (brand name: JumpStart) in preventing the spread of Propionibacterium acnes in patients receiving open or arthroscopic shoulder surgery.

What is the current status of trial NCT03466658?

This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2018-11-01. Estimated completion is 2019-08-01.

What interventions are being tested in trial NCT03466658?

The interventions under investigation include: JumpStart Antimicrobial Wound Dressing (DEVICE).

Who is sponsoring clinical trial NCT03466658?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03466658's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03466658, the US trial registry maintained by the National Library of Medicine. NCT03466658 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.